Physician profile
Anthony N Dardano
NPI 1215158969
$1,708.33
in general payments reported to CMS, 2019-2025
18 companies · $886 in 2025
The $886 reported for 2025 was more than what 99% of Hospice and Palliative Medicine (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.39 · 2022: $362 · 2023: $74.51 · 2024: $320 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036 · Travel and Lodging: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.74 |
| Travel and Lodging | $244.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $840.81 | 2025 | |
| Acera Surgical, INC. | $153.35 | 2024 | Restrata Wound Matrix |
| Solventum Corporation | $145.22 | 2024 | V.A.C. Veraflo, 3m Ioban |
| Shockwave Medical, INC | $140.40 | 2022 | |
| Depuy Synthes Sales INC. | $116.02 | 2022 | |
| Merck Sharp & Dohme LLC | $37.60 | 2021-2022 | |
| Boston Scientific Corporation | $31.74 | 2022 | |
| Seagen INC. | $31.45 | 2022 | |
| Lilly USA, LLC | $27.43 | 2023 | Retevmo, Jaypirca |
| Davol INC. | $26.06 | 2025 | Arista |
| Astrazeneca Pharmaceuticals Lp | $24.51 | 2023 | Tagrisso |
| Sun Pharmaceutical Industries INC. | $23.63 | 2022 | |
| Abbvie INC. | $22.57 | 2023 | Botox |
| Mentor Worldwide LLC | $21.56 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Csl Behring | $20.06 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $18.68 | 2025 | Onetrac Lx |
| Morphosys, US INC. | $15.37 | 2021 | |
| Tela Bio, INC. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Dardano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.